Switching treatments

Exposure

1 paper1 finding

  • 1 lab
  • Humans1

Associations

1

Adverse events

upin humans1

1 study
  1. Switching treatments raise the risk of adverse events in humans (p <0.001).

    “Participants who switched treatments consistently reported higher overall and category-specific AE rates (all p <0.001)”

    Humansswitching GLP-1/GIP therapies vs continuous single treatment

    Comparing Adverse Event Rates among GLP-1/GIP Therapy Switchers vs. Continuous Use Groups in a Real-World Telehealth Cohort

    ADA Scientific Sessions 2026 abstract5 Jun 2026

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months